Yafei F. Zhang
79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Identification and Localization of Functioning Gastroenteropancreatic Neuroendocrine Tumors Using [18F]F-NOTA-octreotide PET/CT.
Journal: Journal of visualized experiments : JoVE
Published: April 20, 2026
The role of 18F-FDG PET/CT in the clinical evaluation of hepatoid adenocarcinoma.
Journal: Abdominal radiology (New York)
Published: April 04, 2026
Radiosynthesis and Preclinical Evaluation of [68Ga]Ga-NOTA-PTP Profiling Plectin-1 Expression for Pancreatic Cancer Imaging.
Journal: Journal of medicinal chemistry
Published: January 28, 2026
[18F]AlF-NOTA-FAPI-04 PET/CT outperforms contrast-enhanced CT and contrast-enhanced MRI in clinical staging evaluation of patients with initial pancreatic cancer.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 18, 2025
Atypical clinicopathological features of monomorphic epitheliotropic intestinal T-cell lymphoma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 31, 2025
Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy.
Journal: Bone marrow transplantation
Published: August 05, 2025
Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment 18F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer.
Journal: BMC cancer
Published: November 25, 2024
Characteristics of 18F-FAPI-04 PET/CT in patients with peritoneal metastasis and to predict treatment efficacy, a head-to-head comparison with 18F-FDG PET/CT.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 01, 2024
Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 21, 2024
Clinical Utility of 18Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With 18Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Journal: MedComm
Published: August 08, 2024
Last Updated: 09/26/2026